H. Mersebach et al., Intestinal adsorption of levothyroxine by antacids and laxatives: Case stories and in vitro experiments, PHARM TOX, 84(3), 1999, pp. 107-109
Two patients with hypothyroidism treated for upper dyspepsia and constipati
on with aluminum hydroxide and magnesium oxide, respectively presented a ma
rked increase in the serum concentration of thyroid stimulating hormone and
low serum thyroxine on a fixed dosage of levothyroxine. After discontinuat
ion of antacids/laxatives, thyroid stimulating hormone was again reduced in
dicating interaction between levothyroxine and antacids/laxatives. In vitro
studies revealed a dose-related increased adsorption of levothyroxine by a
ddition of a combination of aluminum hydroxide, magnesium hydroxide and mag
nesium carbonate, while no connection between levothyroxine and the additio
n of magnesium oxide, alone, was found. This finding has major clinical con
sequences since 1) many patients are treated with levothyroxine, 2) most pa
tients do not tell physicians that they take antacids/laxatives, and 3) con
sumption of antacids/laxatives in patients with levothyroxine-treated hypot
hyroidism may lead to serious undersubstitution with levothyroxine.